[New advances of artificial intelligence in the diagnosis of non-alcoholic fatty liver disease].

Artificial intelligence (AI) refers to the use of computer programs to simulate and extend human intelligence, and has application prospects in the diagnosis and treatment of diseases. This review focuses on the research status of the screening and diagnosis of NAFLD and nonalcoholic steatohepatitis using artificial intelligence technology, electronic health record data, multi-omics prediction models, image recognition technology based on liver imaging and pathological biopsy, and new drugs research and development, with a view to provide new ideas for the diagnosis and treatment.人工智能（AI）是指用于模拟和扩展人类智能的计算机程序，在疾病诊治中具有应用前景。通过综述AI在非酒精性脂肪性肝病（NAFLD）中的研究现状，着重阐述基于电子病历数据、多组学的预测模型和基于肝脏影像和病理活检的图像识别，对NAFLD和非酒精性脂肪型肝炎疾病筛查、诊断和新药研发中的应用，为NAFLD的诊疗提供新思路。.